Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Cellular Signalling
|
September 22, 2017
GPCRs: Emerging anti-cancer drug targets
Ainhoa Nieto Gutierrez, Patricia H McDonald
Drug Discovery Today. Technologies
|
January 11, 2011
Seeking Ligand Bias: Assessing GPCR Coupling to Beta-Arrestins for Drug Discovery
Laura M Bohn, Patricia H McDonald
Cellular Signalling
|
April 11, 2015
The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism
James D Robinson, Patricia H McDonald
Assay and Drug Development Technologies
|
September 19, 2019
A Nonradioactive High-Throughput Screening-Compatible Cell-Based Assay to Identify Inhibitors of the Monocarboxylate Transporter Protein 1
T Liz Bailey, Ainhoa Nieto, Patricia H McDonald
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 2003
The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction
Magnus M Berglund, Douglas A Schober, Michael A Statnick, et al.
Plos One
|
January 21, 2022
Coordination games in cancer
Péter Bayer, Robert A Gatenby, Patricia H McDonald, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 7, 2014
The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1)
Paolo Di Fruscia, Yuanjun He, Marcel Koenig, et al.
Cell Death and Differentiation
|
September 12, 2019
βarrestin-1 regulates DNA repair by acting as an E3-ubiquitin ligase adaptor for 53BP1
Ainhoa Nieto, Makoto R Hara, Victor Quereda, et al.
Current Issues in Molecular Biology
|
March 26, 2025
Unravelling Convergent Signaling Mechanisms Underlying the Aging-Disease Nexus Using Computational Language Analysis
Marina Junyent, Haki Noori, Robin De Schepper, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 24, 2012
Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists
Rong Jiang, Xinyi Song, Purva Bali, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Cellular Signalling
|
September 22, 2017
GPCRs: Emerging anti-cancer drug targets
Ainhoa Nieto Gutierrez, Patricia H McDonald
Drug Discovery Today. Technologies
|
January 11, 2011
Seeking Ligand Bias: Assessing GPCR Coupling to Beta-Arrestins for Drug Discovery
Laura M Bohn, Patricia H McDonald
Cellular Signalling
|
April 11, 2015
The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism
James D Robinson, Patricia H McDonald
Assay and Drug Development Technologies
|
September 19, 2019
A Nonradioactive High-Throughput Screening-Compatible Cell-Based Assay to Identify Inhibitors of the Monocarboxylate Transporter Protein 1
T Liz Bailey, Ainhoa Nieto, Patricia H McDonald
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 2003
The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction
Magnus M Berglund, Douglas A Schober, Michael A Statnick, et al.
Plos One
|
January 21, 2022
Coordination games in cancer
Péter Bayer, Robert A Gatenby, Patricia H McDonald, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 7, 2014
The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1)
Paolo Di Fruscia, Yuanjun He, Marcel Koenig, et al.
Cell Death and Differentiation
|
September 12, 2019
βarrestin-1 regulates DNA repair by acting as an E3-ubiquitin ligase adaptor for 53BP1
Ainhoa Nieto, Makoto R Hara, Victor Quereda, et al.
Current Issues in Molecular Biology
|
March 26, 2025
Unravelling Convergent Signaling Mechanisms Underlying the Aging-Disease Nexus Using Computational Language Analysis
Marina Junyent, Haki Noori, Robin De Schepper, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 24, 2012
Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists
Rong Jiang, Xinyi Song, Purva Bali, et al.
Page
of 2